Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar

The Danish company's diabetes and obesity division performed particularly well, bolstered by interest in its blockbuster injection Wegovy.

from Health and Science https://ift.tt/NABqKHU
https://ift.tt/Z5A6zQH
https://ift.tt/yxZrido